Prostate Stimulation for Sexual Dysfunction

Status Recruiting

Clinical Trial Summary

The purpose of this study is to use a device to stimulate the prostate with a goal of helping improve symptoms in men with sexual dysfunction.

Clinical Trial Description

The purpose of the study is to use a device to stimulate the prostate. The goal of this is to help men with sexual dysfunction. Sexual dysfunction can include conditions like delayed ejaculation (e.g.takes more than 21 minutes to climax) and can hopefully assist them in achieving faster time to ejaculation (e.g. closer to the median of 5.4 minutes in a "normal" individual) along with erectile dysfunction (e.g. the inability to achieve and sustain an erection). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05468931
Study type	Interventional
Source	Stanford University
Contact	Satvir Basran
Phone	650-723-0948
Email	sbasran@stanford.edu
Status	Recruiting
Phase	N/A
Start date	April 18, 2024
Completion date	June 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05366504` - LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment	Phase 2/Phase 3
Recruiting	`NCT02745808` - Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes	Phase 1
Recruiting	`NCT02573805` - the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males	N/A
Withdrawn	`NCT02579148` - Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes	Phase 1
Withdrawn	`NCT01967251` - Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction	Phase 2
Recruiting	`NCT02225548` - Sagene 2014 - Parkinson's Disease and Erectile Dysfunction	Phase 4
Completed	`NCT02587988` - Trial to Evaluate the Efficacy and Safety of HCP1302	Phase 3
Completed	`NCT01937871` - A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)	Phase 3
Completed	`NCT02945462` - Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED)	Phase 1
Completed	`NCT01698684` - Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction	Phase 4
Not yet recruiting	`NCT01321489` - A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies	Phase 3
Completed	`NCT01230541` - Effect of Udenafil on Spermatogenesis	Phase 1
Terminated	`NCT01262833` - Pudendal Assessment in Erectile Dysfunction	N/A
Completed	`NCT02226237` - Effectiveness of Physiotherapy to Treat the Urinary Incontinence and Erectile Dysfunction Post Retropubic Prostatectomy	N/A
Completed	`NCT01037218` - Treatment of Erectile Dysfunction II	Phase 3
Completed	`NCT01037244` - Treatment of Erectile Dysfunction I	Phase 3
Recruiting	`NCT00313898` - Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning Males	Phase 4
Completed	`NCT00667979` - Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse	Phase 4
Completed	`NCT00663728` - Assessment of Duration of Erection With Vardenafil 10 mg	Phase 4
Completed	`NCT00421083` - Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury	Phase 3